Statins may lower mortality risk in kidney cancer patients

05/8/2013 | HealthDay News

An analysis of data from more than 900 patients who underwent surgery for renal cell carcinoma showed that statin use was associated with a lower risk of cancer progression and death. Nearly four years after surgery, 10% of statin users died of kidney cancer compared with 17% of nonusers, researchers found. The findings were reported at the annual meeting of the American Urological Association.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA